Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
The report details the trend, potential and market size of Oral Anti-Diabetic Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Anti-Diabetic Drugmarket, defines the market attractiveness level of Oral Anti-Diabetic Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oral Anti-Diabetic Drug industry, describes the types of Oral Anti-Diabetic Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Anti-Diabetic Drug market and the development prospects and opportunities of Oral Anti-Diabetic Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Anti-Diabetic Drug market in Chapter 13.
By Player:
Abbott
Janssen Pharmaceuticals
Merck And Co
Eli Lilly
AstraZeneca
Bristol Myers Squibb
Boehringer Ingelheim
Sanofi
Biocon
Novartis
Astellas
Takeda
Pfizer
By Type:
Glimepiride
Gliclazide
Glyburide
Others
By End-User:
Hospital
Research Institual
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oral Anti-Diabetic Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oral Anti-Diabetic Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oral Anti-Diabetic Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oral Anti-Diabetic Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oral Anti-Diabetic Drug Market Analysis and Outlook to 2022
-
7.1 Global Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.2 United States Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.3 Europe Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.4 China Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.5 Japan Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.6 India Oral Anti-Diabetic Drug Consumption (2017-2022)
-
7.7 South Korea Oral Anti-Diabetic Drug Consumption (2017-2022)
8 Region and Country-wise Oral Anti-Diabetic Drug Market Analysis and Outlook to 2028
-
8.1 Global Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.2 United States Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.3 Europe Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.4 China Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.5 Japan Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.6 India Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Oral Anti-Diabetic Drug Consumption Forecast (2022-2028)
9 Global Oral Anti-Diabetic Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Anti-Diabetic Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glimepiride Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gliclazide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glyburide Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Anti-Diabetic Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institual Consumption and Growth Rate (2017-2022)
10 Global Oral Anti-Diabetic Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glimepiride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Gliclazide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glyburide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institual Consumption Forecast and Growth Rate (2022-2028)
11 Global Oral Anti-Diabetic Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oral Anti-Diabetic Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oral Anti-Diabetic Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oral Anti-Diabetic Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oral Anti-Diabetic Drug Market Competitive Analysis
-
14.1 Abbott
-
14.1.1 Abbott Company Details
-
14.1.2 Abbott Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Oral Anti-Diabetic Drug Product and Service
-
14.2 Janssen Pharmaceuticals
-
14.2.1 Janssen Pharmaceuticals Company Details
-
14.2.2 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product and Service
-
14.3 Merck And Co
-
14.3.1 Merck And Co Company Details
-
14.3.2 Merck And Co Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck And Co Oral Anti-Diabetic Drug Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly Oral Anti-Diabetic Drug Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Oral Anti-Diabetic Drug Product and Service
-
14.6 Bristol Myers Squibb
-
14.6.1 Bristol Myers Squibb Company Details
-
14.6.2 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Product and Service
-
14.7 Boehringer Ingelheim
-
14.7.1 Boehringer Ingelheim Company Details
-
14.7.2 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Oral Anti-Diabetic Drug Product and Service
-
14.9 Biocon
-
14.9.1 Biocon Company Details
-
14.9.2 Biocon Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biocon Oral Anti-Diabetic Drug Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Oral Anti-Diabetic Drug Product and Service
-
14.11 Astellas
-
14.11.1 Astellas Company Details
-
14.11.2 Astellas Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Astellas Oral Anti-Diabetic Drug Product and Service
-
14.12 Takeda
-
14.12.1 Takeda Company Details
-
14.12.2 Takeda Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Takeda Oral Anti-Diabetic Drug Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Oral Anti-Diabetic Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oral Anti-Diabetic Drug
-
Figure Oral Anti-Diabetic Drug Picture
-
Table Global Oral Anti-Diabetic Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Anti-Diabetic Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Anti-Diabetic Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oral Anti-Diabetic Drug Consumption by Country (2017-2022)
-
Figure United States Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Figure China Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Figure India Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Anti-Diabetic Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Anti-Diabetic Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Anti-Diabetic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glimepiride Consumption and Growth Rate (2017-2022)
-
Figure Global Gliclazide Consumption and Growth Rate (2017-2022)
-
Figure Global Glyburide Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institual Consumption and Growth Rate (2017-2022)
-
Figure Global Glimepiride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gliclazide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glyburide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institual Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oral Anti-Diabetic Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oral Anti-Diabetic Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Oral Anti-Diabetic Drug Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product and Service
-
Table Merck And Co (Foundation Year, Company Profile and etc.)
-
Table Merck And Co Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck And Co Oral Anti-Diabetic Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oral Anti-Diabetic Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oral Anti-Diabetic Drug Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oral Anti-Diabetic Drug Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Oral Anti-Diabetic Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oral Anti-Diabetic Drug Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Oral Anti-Diabetic Drug Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Oral Anti-Diabetic Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oral Anti-Diabetic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oral Anti-Diabetic Drug Product and Service
-
